PROPERTIES OF FIBRONECTIN
Some properties of huma n plasma fibronectin are given in t he Table. It is a fast ,B-globulin with a sedimentation coefficient (S~o.w) of about 13 and a molecular mass, based on sedimentation equilibrium, of 440 kilodaltons (kd). Its frictional ratio is about 1. 7. The properties of cell culture fibronectin are similar except that, as discussed below, cell culture fibronectin is 100-fold less soluble than plasma fibronectin in physiological saline. Spectroscopic and hydrodynamic studies in various solvents suggest that both plasma and cell culture fibronectin have globular and fl exible regions inasmuch as t he sedimentation coefficient can change markedly in the absence of changes in spectroscopic properties.
Soluble fibronectin is a disulfide-bonded dimer of 200 to 250 kd subu nits, as judged by polyacrylamide gel electrophoresis in sodium dodecyl sulfate with and without prior reduction. Reduced plasma fibronectin often migrates in these gels as 2 closely-spaced bands of equal intensity. Fibronectin secreted or shed by cultured cells migrates as a diffuse band, and differences in the ratio of labeled carbohydrate to labeled protein can be shown across the band in double label experiments. Some laboratories have found that the apparent subunit size (in sodium dodecyl sulfate-polyacrylamide gels) of fibronectin secreted by cells in culture is slightly larger than plasma fibro- Insoluble fibronectin extracted from the cell layer of cultured cells is present as both disulfide-bonded dimers and multimers. Pulse labeling studies of cultured chick fibroblasts indicate that fibronectin is synthesized as a dimer and converts to a multimer with biphasic kinetics. Such studies suggest that the cysteines of the fibronectin dimer are oxidized in the cell layer and form disulfide bridges to adjacent fibronectin dimers, and that formation of disulfide-bonded multimers contributes to the insolubility of cell layer fibronectin under physiological conditions. Further studies are needed to determine whether fibronectin in tissue stroma is also composed of disulfide-bonded multimers.
Disulfide-bonded multimers of fibronectin extracted from cell layers of normal cultured cells have the property of causing transformed cultured fibroblasts, which generally lack a fibronectin matrix, to assume more normal morphology, to have increased adhesion to the substratum, and to have less cell surface microvilli and membrane ruffles. To do these experiments, the fibronectin is solubilized in alkaline buffer and neutralized just prior to being added to the transformed cells. The added fibronectin forms a matrix which, by immunofluorescence, is strikingly similar to that seen in non transformed cultures. Plasma fibronectin is less active than isolated cell layer fibronectin in restoring morphology, and reduction of cell layer fibronectin with dithiothreitol interferes with its ability to restore morphology. Thus, the disulfide-bonded fibronectin multin1er has biological properties which are not shared by the fibronectin dimer.
MODEL OF FIBRONECTIN BASED UPON
. PROTEOLYTIC CLEAVAGES Cleavage of the large polyfunctional fibronectin subunit with a variety of proteases results in fragments which retain one or more properties of the intact molecule (Fig 1) . Three regions have been identified. The 27 kd tryptic fragment from the NH2-terminus is basic, contains F. XIII" (plasma transglutaminase) reactive glutaminyl residues, binds to S. aureus and to fibrin, and mediates F. XIII,,-catalyzed cross-linking. to collagen. Strong noncovalent binding to collagen is mediated by the adjacent 30-60 kd region. The COOH-terminal region is responsible for binding the heparin and for cell adhesive activity. The 2 free cysteines per subunit are in the COOH-terminal onethird of the subunit. Dimerization of the subunit is mediated by interchain disulfide (s) at the extreme COOH-terminus.
INTERACTION OF FIBRONECTIN WITH FIBRINOGEN AND FIBRIN
The concentration of fibronectin in serum is 20-50 % less than the concentration in plasma; this difference is greater if clotting is carried out at 0-4°C. Loss of fibronectin into the clot at 22-37°C is due to F. XIII,,-catalyzed covalent cross-linking (by E-(y-glu tamyl) lysine linkages) between fibronectin and the a chain of fibrin. Loss of fibronectin into the clot at lower tem- peratuTes is due to both noncovalent binding and covalent cross-linking . . The only other plasma protein known to be incorporated into the clot in a F . XIII,,-dependent manner is a 2-plasmin inhibitor. Assuming that the concentration offibrinogen in plasma is 2,400 /lg/ml, of which 100% is incorporated into the clot; that the concentration of fibronectin in plasma is 320 /lg/ ml, of which 35 % is incorporated into the clot; and that the concentration of a 2-plasrnin inhibitor in plasma is 69 /lg/ml, of which 24 % is incorporated into the clot; the mass of the clot would be 94.9 % fibrin, 4.4 % fibronectin, and 0.7% a 2-plasmin inhibitor.
Fibronectin is necessary for cryoprecipitation of fibrinogenfibrin complexes, even when the complexes are saturated with fibrin. Fibronectin probably acts as a nucleus, because the ratio of fibronectin:fibrinogen:fibrin in the precipitated complexes is approximately 0.05:0.8:0.2. Such complexes are found in plasma of patients with "cryofibrinogenemia" and cruonic disseminated intravascular coagulation. Fibronectin is also necessary for the formation of a precipitate in heparinized plasma at 2°C. Although the heparin-precipitable fraction from normal plasma contains about 65 % fibrinogen and 35 % fibronectin, the precipitate can be formed from plasma which lacks fibrinogen. In a purified system, the amount of precipitation depends upon fibronectin concentration, heparin concentration, pH, ionic strength, and calcium ion concentration. For a given set of conditions, the amount of precipitation is increased if fibrinogen is also present. Optimal precipitation OCCUl'S when fibronectin and heparin are present in a 3:1 '(w/w) ratio. The participation of fibrinogen or fibrin in the cryoprecipitation or cold heparin precipitation reactio.ns requires intact a chains; fibrinogen and fibrin molecules which lack the carboxyl terminal region of the a chain are excluded from these precipitates.
Fibronectin which has been cross-linked to fibrin only subtly alters the properties of the clot. Fine clots (i.e., clots consisting of fine fibi'ils with few branch points, formed at high ionic strength and pH) to which fibronectin is cross-linked at 22°C have half the elastic modulus of cross-linked fine clots which lack fibronectin, whereas coru'se clots (i.e., clots consisting of coarse fibrils with many branch points, formed at low pH and ionic strength) to which fibronectin is cross-linked at 22°C have twice the elastic modulus of cross-linked coarse clots which lack Vol. 77, No.2 fibronectin. Cross-linking of fibronectin to fibrin, however, profoundly enhances the attachment and spreading of cells on a fibrin-coated substratum. Thus, covalent attachment of fibronectin to fibrin may be important for adhesion and migration of cells into a wound.
INTERACTION OF FIBRONECTIN WITH COLLAGEN AND GLYCOSAMINOGL YCANS
Fibronectin binds and can be cross-linked (by F. XIII,,) to several types and forms of collagen. Although there ru'e conflicts in the literatw'e, several generalizations seem true. First, at 4 ° and 20°C, fibronectin interacts better with denatUl'ed collagen a nd collagen fragments than with native collagen. Second, at 37°C the interaction of fibronectin with native Type I collagen . is only at the site of cleavage of collagen by vertebrate collagenase. Because collagenase cleaves the al(I) chain of T ype I collagen in a region which lacks proline and hydroxyproline over a span of 12 residues, there may be local uncoiling of the collagen helix in this region at 37°C. Third, interstitial collagens (Types I, II, and III) interact better with fibronectin than basement membrane collagens (Types IV and V) .
There is evidence for interactions of fibronectin with h epru'in, more heavily sulfated forms of heparan sulfate, hyalUl'onic acid, and chondroitin sulfate-containing proteoglycan. At 4°C, heparin induces precipitation of plasma fibronectin into filamentous structures. The fraction of heparin which is present in heparin-precipitated fibronectin is not enriched or depleted in anticoagulant activity. Heparin-precipitated fibronectin binds fibrinogen and native collagen. Passage of heparin or heavily sulfated heparan sulfate over a column of gelatin-agarose to which fibronectin has been previously bound strengthens the fibronectin-gelatin interaction. Although hyalUl'onic acid does not compete for binding of heparin to fibronectin, it is an effective inhibitor of fibronectin -heparin-induced precipitation of native collagen.
. The interactions among hyaluronic acid, heparan sulfate, collagen, and fibronectin may be important for cell motility. Adhesive footpads of cu~tured cells sheared from a substratum are rich in fibronectin and heparan sulfate, whereas hyaluronic acid and chondroitin sulfate are coordinately deposited in footprints left behind by cells moving over a substratum. These findings indicate that heparan sulfate is involved in adhesion to substratum, perhaps by binding to fibronectin, and that h yaluronate-chondroitin complexes may labilize the footpad adhesions, with subsequent cytoskeletal disorganization and cell movement.
INTERACTION OF FIBRONECTIN WITH CELLS
A variety of cell types adhere to fibronectin which has ad~ sorbed to tissue culture plastic at sites of nonspecific protein adsorption, to fibronectin which has specifically adsorbed to collagen, or to fibronectin which has been cross-linked to fibrin . In each of these systems, soluble fibronectin does not compete with adsorbed fibronectin and does not inhibit cell adhesion and spreading. Thus, suspended cells are unable to "arm" themselves with fibronectin and do not deplete the suspension of soluble fibronectin. The cellular "receptor" for fibronectin may involve a di-or tri-sialoganglioside and a ricin-binding glycoprotein.
The opportunity to adhere to fibronectin seems to be very important for many cell types. For example, being in cuituTe . dishes to which fibronectin has been adsorbed allows cytokinesis and growth of rat follicular cells in serum-free medium and migration of transformed hamster fibroblasts. Not all cell types requiTe fibronectin for adhesion, however [6] . Chondrocyte adhesion to type II collagen is stimulated by a protein called chondronectin, which is present in fetal serum and cartilage. PAM 212 epidermal cells attach preferentially to type IV collagen and make an adhesion factor called laminin [7) .
INTERACTION OF FIBRONECTIN WITH BACTERIA
Fibronectin binds specifically to Staphylococcus aureus bu t not to Escherichia coli or Mycobacterium butyricum. Binding of fibron ectin to S. aureus is only slightly inhibited by denatured collage n and is not inhibited by Protein A, the immunoglobulin binding protein of S . aureus. The n ature of t h e bacterial component to which fibronectin binds is not known at present. The interaction of fibronectin with bacteria is of potential importance both for the opsonization of bacteri a by soluble fibronectin and the attachment of bacteria to insoluble tissue fibronectin.
INTERACTIONS OF FIBRONECTIN WITH ACTIN AND DNA
Fibronectin binds to coulumns of actin-agarose and DNAagarose under physiological conditions. Thus, fibronectin is one of the DNA-binding proteins of serum. It is not known whether t he cellula r compartmentilization of fibron ectin, ac tin, a nd DNA all ows interactions to occur in whole celis. In cul t ured cells, th e distribution of extracellular fibrone ctin a nd intracellular actin by immunofluorescence can be rem arkably similar. By immunoelectromicroscopy, structures containing the 2 prot~in s a re separated by less than 8-22 nm across the cell m embrane. On t h e basis of these findings, a transmembra ne protein has been postulated to link togeth er fibronectin fibrils on the outside of t he cell with cytoplasmic actin microma ments on t h e inside.
SYNTHESIS AND DISTRIBUTION OF FIBRONECTIN IN CELL CULTURE Synthesis of fibronectin in cul t ure has been demonstrated for a number of cell ty pes, including fibroblasts, vascular endot h elia l cells, corneal endothelial celis, smooth muscle cells, astrogIial cells, Schwa nn cells, glomerular cells, intestinal epithelia l cells, breast epithelial cells, kidney a nd liver epithelial cells,
hepatocytes, chondrocytes, myoblasts, mac ro phages, and teratocarcinoma cells. Large a moun ts of fibronectin are synth esized . For instance, cul tures of huma n embryo nic fibroblasts produce abou t 120 /l-g fibro nectin per mg cell protein per 24 hr. A large percentage (60-95%) of t h e fibronectin is ra pidly secreted into the medium; a smaller percen tage remains as trypsin-sensit ive extracellula r protein in the cell layer. Extracellular fibronectin accumulates in t h e cell layer of cul t ured cells in patterns which vary from cell type to cet! type. In fibroblast cult ures, the earliest fibronectin detectable by immunofluorescence is betwee n t he cells a nd the cult ure dish a nd co-distributes with cytoplasmic actin micromaments. As cells grow to confluence, fibronectin , a lo ng with procollagen, acc umulates at sites of ceJlto-cell contact (Fig 2) . Conflue nt fibroblast cul tures h ave a n extracellular fibrill ar m atrix which r eacts with antibodies to fibrone ctin a nd types I and III procollagen a nd collage n (Fig 2) a nd stains with ruthenium r ed, a dye which is known to bind to proteoglycans. When human fibroblas ts are left in cultw'e for several weeks or ar e treated with ascorbate, t h e fibrils become t hicker (40-50 nm diameter rath er than 10-20 nm) and ex hibit 67 nm periodicity when stained by a n immunoperoxidase techni q ue for fibronectin or type I procollagen a nd examined by electron microscopy (Fig 3) . Fibronectin is present within t h e m atrix in disulfide-bonded multimers as weJl as dimers a nd is susceptible to cross-linking by F . XIII".
Cul t ured fibroblasts passing through mi tosis lose surfaceassociated fibronectin a nd then regain it as t h ey flatten in telophase. Other circumstances which cause rounding of cells, su ch as transformation or treatment wit h cytoch alsin B , also cause loss of cell surface-associated fibron ectin. Loss of fibronectin is presumably due to .cha nges in in t racellular actin microfila m ents.
Association of cells with a fibro nectin matrix has dramatic effects which may be of great pathophysiologic impor ta nce. Cul t ured t ransformed cells acq uire a more normal appearance FIBRONECTIN 177 (b ut not norma l growth con t rol) when a m atrix is reconstituted with materi a l extracted from normal cultures. Chondrocytes a nd myo blasts have fibronectin m atrices in their undifferentiated state. These matrices ar e lost when chondrocytes synt h esize type II collage n or m yo blasts fu se a nd form m yotubes. Differentiat ion, however, is blocked when fibronectin m atrices are reconstitu ted with ma t rix materia l from fibroblast cul tures. The labile stat e of t h e chondrocyte phenotype m ay be of crucia l importa nce in th e replacement of car tilage by fibrous t issu e in rheumatoid a rthri t is a nd osteoarthrit is. Confluent vascular a nd corneal endoth elial cells bind but do no t take up low d ensity li popr otein . F a ilure to ta ke up low density lipoprotein by endocytosis h as been correlated wit h acquisition of a fibron ecti n matrix between t h e endo thelial ceLIs a nd substrat um a nd may be a m ech anism that preven ts fatty degener ation of blood vessel .
DISTRIBUTION OF FIBRONECTIN IN TISSUES
Fibronectin can be visua li zed by immunofluorescence in the very early embryo, a nd its pattern ch a nges through ou t developm en t. It is present in areas of cell migration, is present (a long with types I a nd III collagen) in differentiating m esen chyme, and is associated with limi ti ng m embranes of fully fo rmed organs. It is also present in loose connective t issue. The distribution of fibronectin in vivo is compatible wit h t h e distribution of fibron ectin in cell cul t ure a nd with fibron ectin's putative fun ctions in cell ad hesion , cell migr ation, cell differentiation , a nd t issue stromal or ganization.
Wi t hin rat a nd huma n sk in (8) (9) (10) , fibronectin is absent from stable, differ en t iated pa rts of t he tissue, su ch as sebaceo us gla nds or t h e m atri x, medulla, cortex, a nd cuticles of th e ha ir a nd the inner a nd ou ter root sheaths or t h e epidermis. Fibronectin is fo und at sites at which cell division is occurring in co ntact with a n extracellular scaffolding, as in t h e glassy membrane a nd connective tissue sheath associated with folli cular epit h elium , t he basem ent m embran e underly ing vascular endothelia l ceLIs, and the connective tissu es surrounding a nd in vesting nerve a nd muscle fibre bundles. At t he basem ent membra ne of t he dennal/epidermal junction, fibronectin occurs at th e plasm a m embra ne of th e basal cells and in t h e la mina lucida . Fibronectin is associated with collage n fib ers in derm a l conn ective t issues a nd is pre ent within the endoplasmic r eticulum of d ermal fibroblasts.
During exp erimental wo und h ealing (ll] and granuloma forma tion (1 2], fibronectin is presen t in large amo unts in fibrin clots a nd in t h e regene rating tissue matrix . A marked increase in fibronectin is found in t h e deep dermis of involved scleroderma skin in pa rallel with the increase in collagen (13, 14] . In affected s kin in systemic a nd systemic lupus erythematosus, t her e a re cha nges in t h e distribution of fibronectin in the demlal/ep iden nal ' junction and in t he papillary dermis (15] . T her e ar e fibronectin-negative gaps and sli t formation in t h e dermal/epidermal region , togeth er with fibron ectin-positive globu la r bod ies a nd transport of fibronectin into t h e epidermis.
FIBRONECTIN AS AN OPSONIN
Following injection of p hagocytic material, the phagocytic system is refr acto ry for s~ve ra l hours to ch a llenge by a second phagocytic stimulus. The depression in phagocytic activity is due, at least in pa rt, to depletion of fibronectin . Animals with low fibronectin concen t ration do not clear gelatin-coated par
Loca li zation of ty pe I procollagen a nd fibro nectin on you ng cultured huma n s kin fibroblasts. a, E lectron micrograph of type I proco ll agen localization on ve ry low density human fibroblasts. Very s ma ll a mou n ts of proco llagen type I localization product are presen t on t he s urfaces of non co ntacting cells. Occasiona lly s ma ll discrete patches of procoll agen ar e seen (arrows); however, most membra ne sw-faces a.re free of staining ( x 3,800). b, E lectron mi crog ra ph of fibronectin localization on very low density human fibrobl asts. Patches of nonfibrillar fibron ec tin a.re prese nt on the pl asma lemma of most cells (a.rrows). The extens ive vesicles seen in hi gh dens ity cul tures a re not presen t (x 5,500) . c, E lectron micrograph of heavy metal co unte rs tain ed t hin section of yo ung conflu en t huma n fibrobl asts. The extracell ular fibrillar matrix (F) has developed. The fibrils are L5-25 nm in di a meter a nd lack periodicity. M any vesicles (V) a re presen t near t he plasma membrane which is difficu lt to discern beca use it is sectioned tangentia lly parall el to the monolayer (x 6,800). d, Ultrastru ctura l localization of procoll agen type I on yo ung conf1uent human fibrob lasts. Type I procoll agen is presen t on bundles of extracellul a r fibri ls as well as in a diffuse form on the plasma membra ne a nd in me mbra ne-associated vesicles. The tangentia lly sectioned membrane is more easily discerned in t h IS micrograph , since it is coated with t he diffu se form of loca li zation product (bel ween facing a.rrows) (x 6,700) . e, Ultrastru ctura l loca li zation of fibrone ctin on the s urface of yo ung confl uent hum a n fibroblasts. Fibronectin is prese nt on the ex tracellula r fibrill a r matrix, in a diffu se form on t he plas ma membrane and a lso in membrane-associated vesicles (seen bes t in Fig 3e a nd other sections grazing t he membrane) (x 5,500). f, E lectro n micrograp h of adsorption co n trol fo r fibroncctin locali zation. No staining is prese nt when ant.ifibronectin is preadsorbed with purified fibronectin ( x 3,800). othe r experime ntal models. However, depression of reticuloe ndothelial system phagocytic activi ty may be seen with norma l cil·cul ating fibronectin concentration , as after endotoxin injections in rats.
C hanges in plasma fibronectin concentration are not commonly assoc iated with severe diseases. Fibronectin is not a n active phase reactant following myocardial infarction . Fibronee tin conce ntration varies amo ng ind ividua ls, a nd females tend to have lower concentrations t han males. Fibronectin concentration is normal in pregnant women, but the concentration can increase several-fold in recurrent cholestasis of pregna ncy. Newborns have 35 % of th e norma l ad ul t plasma concentration of fibronectin . Fibronecti"n is a lso present in a mniotic fluid and cereb rospinal fluid .
T he plasma concentration of fibronectin is probably decreased in seve rely ill patients with disseminated intravascul ar coagulation because of increased utilization' rather than decreased sy nthesis. Experimental d issem inated intravascular coagulation iI;! rabbits causes decreases of both 12r'I-fibronectin a nd 1:Il I-fibrinogen; decreases in '2"I-fibronectin are ·not found in animals initially defibrinated with pit viper venom. These findings indicate that fibronectin complexes with fibrin formed by t hrombin, but not by pit viper venom, a nd t hat t he complexes are rapidly cleared from t he blood. Fibronectin may mediate t he clearance of soluble fibrin by macrophages.
The concentration of plasma fibron ectin that is requ ired for no rma l function is no t known . Patients with less than 50 % of t h e norma l concentration (150 I-tg/ml or less) have a higher mortality than pa tients with normal concentrations. Decreases in fibronectin concentr ation are strongly associated with decreases in t he concentrations of plasminoge n a nd a ,-an tit hrombin, and it may be premature to attribute mortality in a deficiency of fibronectin. Restoration of fibronectin concentration by giving cryoprecipitate, however, has had sometimes dramatic effe cts on pu lmonary function, limb blood flow, and overall clinical well-being in a n ongoing tria l.
FIBRONECTIN, PLATELETS, AND ENDOTHELIAL CELLS
P latelets contain 2-4 I-tg or fibronectin per 10" plate lets or a bout 0.5% of t he blood's conten t of fibronectin. P latelet fibronectin is assoc iated with a granules a nd is released when platelets a re stimulated with t hrombin or collagen. Upon stimulation of was hed platelets, fibronectin can be demonstrated by imJ11unof1u orescence on t h e platelet surface. When washed platelets a re allowed to adhere to collage n a nd t hen sonicated, platelet proteins remaining attached to collagen after sonication are e nrich ed in fibronectin a nd cytoskeletal proteins. Preincubation of collagen with plasma fibronectin at 22°C blocks t he
